GLP-1 Companion with Muscle Defense
Lifestyle support program for GLP-1 medication users
Platform · Cloud SaaSCompany source
Company profile
About Noom
Noom is a comprehensive digital health platform that has been helping people achieve sustainable weight loss and behavior change for over 15 years. The company integrates psychology, technology, and clinical care to address weight management, diabetes prevention, and obesity treatment. Noom's approach focuses on understanding the 'why' behind eating habits through cognitive behavioral therapy (CBT) principles, daily bite-sized lessons, and personalized coaching support enhanced by AI. The platform offers multiple solutions including Noom Weight for psychology-based weight loss, Noom Med for medication-supported weight management featuring GLP-1s like Ozempic, Wegovy, and Mounjaro, and specialized programs for diabetes prevention and management. Noom's GLP-1 Companion program includes Muscle Defense to help users maintain muscle mass while losing fat, along with protein tracking and on-demand workouts. For organizations, Noom provides enterprise solutions for employers, health plans, and health systems, delivering scalable cardiometabolic programs backed by clinical evidence. The company's CDC-recognized Diabetes Prevention Program has earned Full Plus Recognition. Noom serves millions of members globally through its mobile-first platform, offering 24/7 access to coaches, doctors, meal logging, movement tracking, and a supportive community. The company's approach is validated by over 40 peer-reviewed publications demonstrating clinical effectiveness and cost savings.
Company description Noom official website
Mission. We're changing the way the world thinks about weight loss.
Primary marketPatient Engagement & Support
Commercial modelCommercial information available on request
Work at Noom?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiometabolic conditions
- hypertension
- obesity
- overweight
- prediabetes
- type 2 diabetes
Who it serves
- Employers
- Health Plans
- Health Systems
- Individual Consumers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsGermany · South Korea · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Noom Med with GLP-1 Rx Program, GLP-1 Companion with Muscle Defense program, SmartRx pharmacy carve-out solution, Medicare GLP-1 Bridge program (July 2026-December 2027), diabetes management program with medication management (available late 2025)
Partnerships
Recorded partners
- Baptist Health
- CareFirst
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Noom Diabetes Management Program
Psychology-driven type 2 diabetes management with glycemic control
Platform · Cloud SaaSCompany source
Noom Diabetes Prevention Program (DPP)
CDC-recognized digital diabetes prevention program
Platform · Cloud SaaSCompany source
Noom Health (Enterprise)
Digital-first cardiometabolic solutions for health plans and employers
Platform · Cloud SaaSCompany source
Noom Med
Weight-loss medication access with GLP-1 Companion for sustainable results
Platform · Cloud SaaSCompany source
Noom Med (GLP-1 Rx Program)
Weight-loss medication program combining GLP-1s with behavioral support
Platform · Cloud SaaSCompany source
Noom Weight
Psychology-based weight loss program with behavior change curriculum
Platform · Cloud SaaSCompany source
SmartRx
Pharmacy carve-out solution for affordable GLP-1 medication access
Service · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Response to "Critical Appraisal of Health Care Resource Utilization and Health Care Costs Among Digital Weight Loss Intervention Participants and Nonparticipants".Obesity (Silver Spring, Md.) · Jan 1, 2026
Quieting "Food Noise": How GLP-1s and Mindfulness Rewire the Default Mode Network (DMN) and Reward Circuits.Cureus · Jan 1, 2026
Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort Study.JMIR mHealth and uHealth · Sep 24, 2025
Health care resource utilization and health care costs among digital weight-loss intervention participants and nonparticipants.Obesity (Silver Spring, Md.) · Sep 1, 2025
Survival of intact bovine whey proteins across in vivo and simulated static in vitro models of the adult gastrointestinal tract.Food chemistry · Feb 15, 2025
Prototype of an App Designed to Support Self-Management for Health Behaviors and Weight in Women Living With Breast Cancer: Qualitative User Experience Study.JMIR cancer · Dec 20, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Members lost >5% body weight
Millions of members using Noom Weight program
48% more weight loss
Noom Med vs. medications alone
10% savings in prescription costs
Over 2 years for health plan members
Prevented or delayed type 2 diabetes onset
CDC-recognized Diabetes Prevention Program
Improved A1C levels
Type 2 diabetes management program
Baptist Health
Lowering employees' diabetes risk through Noom's diabetes prevention program
Helped lower employees' diabetes risk
CareFirst
Partnership to empower members to take charge of health through healthier habits and weight management to mitigate chronic conditions
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Geoff Cook
Chief Executive Officer
Michael Lanni
Senior Vice President, Head of People
Peter Scherr
Chief Marketing Officer
Jeffrey Egler
Chief Medical Officer
Aaron Severs
Chief Product Officer
Barry Wright, III
Principal Product Manager and Chief of Staff
Daryl Ledyard
Head of Programming, Noom Vibe
Uvika C
Senior Product Manager, Noom Med
06 · Company updates
Updates from Noom
Recent articles published on Noom's official website.
Is there a best tea for weight loss? 7 popular teas, reviewed
Read on NoomWatermelon seeds are surprisingly nutritious (and you can turn them into cheese!)
Read on NoomAre oysters good for weight loss? Here’s when they can be
Read on NoomLow-sugar Starbucks drinks: How to order your favorites with less sugar
Read on NoomHow can I switch from the Wegovy® injection to pill?
Read on Noom07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Patient Engagement & Support
Companies using AI to engage patients, provide health education, facilitate peer support, offer AI health coaching, or help patients navigate their healthcare journey. Includes patient communities, AI health mentors, peer support networks, and platforms that empower patients to take an active role in managing their own health.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.